Dyne Therapeutics: Advancing the Promise of FORCE to Deliver for Patients
Jett’s Community Webinar Series hosts Dyne Therapeutics for a presentation on FORCE, Dyne’s Duchenne clinical trial program.
Community Webinar: Management and Access to Care for Female Carriers of Duchenne
Tune in to hear from Larry Wayne Markham on the management and access to care for female carriers of Duchenne muscular dystrophy.
Community Webinar: PJ’s Protocol Panel
Jett’s Community webinar Series featuring a panel discussion on PJ Nicholoff’s Steroid Protocol.
Community Webinar: Rhabdomyolysis in Duchenne
A presentation and discussion from Dr. Carla Zingariello of the University of Florida on Rhabdomyolysis in Duchenne muscular dystrophy.
Community Webinar: PTC Therapeutics’ 2024 EMFLAZA® Landscape
Information on PTC Therapeutics’ EMFLAZA landscape for 2024 during a presentation and Q&A.
Community Webinar: Social Security and Supplemental Security Disability Benefits
Jett Foundation’s Community Webinar Series featuring a presentation from Delia De Mello on social security and disability benefits.
Navigating the Accessible Vehicle Fund Application Process
Hear from the Jett team on the ins and outs of the Accessible Vehicle Fund application process
Community Webinar: Planning for Travel with a Disability
Jett Foundation’s Community Webinar Series featuring a presentation on how to plan for travel with a disability
Advocating for Yourself During the Transition Process
Jett Foundation’s Community Webinar Series with a presentation and discussion on advocating for yourself during the transition process with Duchenne.
School Accessibility and Participation in Duchenne Muscular Dystrophy
Jett Foundation’s Community Webinar Series presents: School Accessibility and Participation in Duchenne
The Perfect Lift
The founder and creator of “Perfect Lift” joins our Community Webinar Series to discuss product details and use.
Myths Around IEPs and 504 Plans
A Community Webinar hosted by Jett Foundation and Jill Castle on myths around IEPs and 504 plans.
VILTEPSO: An FDA-Approved Duchenne Treatment for Patients Amenable to Exon 53 Skipping
Jett Foundation’s Community Webinar Series with a presentation from NS Pharma on VILTEPSO, an FDA-approved Duchenne treatment
